Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma
The DOI matches its Crossref record.
Abstract
BACKGROUND: Patients with alcoholic cirrhosis show hypogonadism and feminization associated with sex hormone imbalance due to enhanced aromatization of testosterone and subsequent reduced testosterone and increased oestradiol blood levels. Because oestrogens modulate hepatocyte proliferation and oestrogen receptors are present in liver cirrhosis and hepatocellular carcinoma, it has been proposed that sex hormone imbalance can play a role in liver carcinogenesis. Trials with the oestrogen receptor antagonist tamoxifen have been performed with conflicting results. OBJECTIVES: To investigate oestradiol and testosterone blood levels in men with viral cirrhosis and hepatocellular carcinoma and also to investigate changes in sex hormone circulating levels induced by tamoxifen treatment. PATIENTS AND METHODS: Oestradiol and testosterone blood levels were evaluated in 32 male patients with postviral cirrhosis and hepatocellular carcinoma at the time of diagnosis and during the follow-up, and in 20 healthy controls. In eight patients, hormone levels were also assayed during treatment with tamoxifen (40 mg/day). No patient had a history of high alcohol intake. RESULTS: Oestradiol values observed at the time of diagnosis were 56.1 +/- 54.5 pmol/l, while testosterone values were 13.6 +/- 8.0 pmol/l. There was no relationship between oestrogen values and age, while higher oestradiol values were observed in patients with advanced cirrhosis (Child B and C); conversely, testosterone levels progressively and significantly decreased from cirrhosis Child A (15.1 +/- 9.7) to C (7.7 +/- 7.1) (P < 0.05). Tamoxifen treatment (40mg/day) for 1 month in eight patients increased oestradiol values (62.2 +/- 77.0 vs. 156.4 +/- 83 pmol/l, P < 0.05), while testosterone levels decreased (15.1 +/- 6.8 vs. 8.5 +/- 10.6 pmol/l). However, these changes were not associated with clinical signs or symptoms of feminization. Oestrogen levels decreased after 6 months of tamoxifen treatment. No significant change in hormone levels was observed in patients not treated with tamoxifen. Unlike patients with alcoholic cirrhosis, in male patients with viral cirrhosis and hepatocellular carcinoma there were no significant alterations in blood oestradiol and testosterone levels, although a certain degree of sex hormone imbalance was observed in those with advanced cirrhosis. Treatment with tamoxifen (40 mg/day) did not induce clinical manifestations of sex hormone imbalance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rouillard, S., & Lane, N. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20533 · Cited by 125
Osteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
“Hypogonadism is a risk factor for ‘high-turnover’ osteoporosis ([30], #379) but, although it certainly contributes to osteopenia in some patients, it is not the only factor for bone loss in patients with liver disease.”
BackgroundChen, C.-H., Lin, C.-L., & Kao, C.-H. (2015) · Medicine · doi:10.1097/md.0000000000002276 · Cited by 61
“Accelerated bone loss mainly due to increased osteoclast activity caused by hypogonadism with diminished blood levels of estrogen and testosterone is also frequently observed in the presence of decompensated liver.(32) In addition, advanced liver disease will impair the hydroxylation of vitamin D3 to D25 in the liver…”
BackgroundBone mineral density and its determinants in men with opioid dependence
Gotthardt, F., Huber, C., Thierfelder, C., Grize, L., Kraenzlin, M., Scheidegger, C., & Meier, C. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0732-9 · Cited by 55
“Testosterone deficiency is a recognized comorbidity in patients with decompensated cirrhosis and hepatocellular carcinoma [36].”
BackgroundRisk of hip fracture associated with untreated and treated chronic hepatitis B virus infection
Byrne, D. D., Newcomb, C. W., Carbonari, D. M., Nezamzadeh, M. S., Leidl, K. B. F., Herlim, M., Yang, Y.-X., Hennessy, S., Kostman, J. R., Leonard, M. B., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.001 · Cited by 31
Metadata
- Authors
- Pignata, S., Daniele, B., Galati, M. G., Esposito, G., Vallone, P., Fiore, F., Ricchi, P., & Pergola, M.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 1997-03
- Volume
- 9
- Issue
- 3
- Pages
- 283-286
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2007129056
- Cited by
- 37
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma. https://app.cochat.ai/papers/10.1097/00042737-199703000-00012
- The paper
- Pignata, S., Daniele, B., Galati, M. G., Esposito, G., Vallone, P., Fiore, F., Ricchi, P., & Pergola, M. (1997). Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-199703000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.